HNRNPA2B1 and non-small cell lung carcinoma: In NSCLC, Wang et al. (2024) reported that hnRNPA2B1 was found in multidrug-resistant cell lines and hnRNPA2B1 silencing effectively inhibited cell proliferation, enhanced the stemness properties and induced apoptosis to sensitize NSCLC cells to chemotherapy in vitro and in vivo [3].